Serina Therapeutics (SER) Stock: Buy, Sell, or Hold?
$1.50
+0.07 (+4.90%)
▲
5d:
-11.24%
30d:
-17.58%
90d:
-47.37%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (88%)
Quality Score
47/100
Position
OVERSOLD
30-Day Fair Range
$1.57 – $1.94
Position: OVERSOLD
Forward P/E & Valuation
-1.3x
Next 12M consensus est.
Wall Street Target
$9.50
+533.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.14 / $2.55
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: SER is down 11.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When SER Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: SER is currently trading at $1.50, which is considered oversold relative to its 30-day fair value range of $1.57 to $1.94.
Technical Outlook: Technically, SER is in a strong downtrend. Immediate support is located at $1.14, while resistance sits at $2.55. The stock is showing strong short-term momentum, up 4.9% recently.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $9.50 (+533.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SER is in a strong downtrend. Immediate support is located at $1.14, while resistance sits at $2.55. The stock is showing strong short-term momentum, up 4.9% recently.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $9.50 (+533.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.57 -
$1.94
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
Trading Range & Key Levels
30-Day Trading Range
$1.57 -
$1.94
Current vs Trading Range
OVERSOLD
Support Level
$1.14
Resistance Level
$2.55
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (53/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.9%)
- BULLISH: Trading 533.3% below Wall St target ($9.50)
- WARNING: Composite score 47/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-1.30
Wall Street Target
$9.50
(+533.3%)
Revenue Growth (YoY)
154.9%
Earnings Growth (YoY)
-43.5%
Share SER Analysis
Share this live SER analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (SER)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish StockTwits user with 335 followers expressed optimism about Serina Therapeutics ($SER) and its potential in treating Parkinson's disease with a proven molecule and smarter delivery system.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 8:40 AM ET
Data refreshes hourly during market hours. Next update: 9:40 AM
Data refreshes hourly during market hours. Next update: 9:40 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SER showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 31 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 35 SELL |
|
BNTX
BioNTech SE |
BUY
21 analysts |
$114 | 62 BUY |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 41 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 39 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive SER Research Pages
